Toxic Epidermal Necrolysis Associated with Sorafenib and Tosufloxacin in a Patient with Hepatocellular Carcinoma

This is the first case report to describe a 44-year-old woman with a history of advanced hepatocellular carcinoma who developed toxic epidermal necrolysis (TEN) clinically after taking 400 mg sorafenib (Nexavar®, BAY 43-9006) and tosufloxacin orally once per day. Both sorafenib and tosufloxacin were...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Mun Ki, Woo, Hyun Young, Heo, Jeong, Cho, Mong, Kim, Gwang Ha, Song, Geun Am, Kim, Moon Bum
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Dermatological Association; The Korean Society for Investigative Dermatology 2011
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3276809/
https://www.ncbi.nlm.nih.gov/pubmed/22346290
http://dx.doi.org/10.5021/ad.2011.23.S3.S404

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3276809/
https://www.ncbi.nlm.nih.gov/pubmed/22346290
http://dx.doi.org/10.5021/ad.2011.23.S3.S404

Ejemplares similares